215 related articles for article (PubMed ID: 28978109)
1. Sorafenib inhibits therapeutic induction of necroptosis in acute leukemia cells.
Feldmann F; Schenk B; Martens S; Vandenabeele P; Fulda S
Oncotarget; 2017 Sep; 8(40):68208-68220. PubMed ID: 28978109
[TBL] [Abstract][Full Text] [Related]
2. Smac mimetic triggers necroptosis in pancreatic carcinoma cells when caspase activation is blocked.
Hannes S; Abhari BA; Fulda S
Cancer Lett; 2016 Sep; 380(1):31-8. PubMed ID: 27267809
[TBL] [Abstract][Full Text] [Related]
3. Smac mimetic primes apoptosis-resistant acute myeloid leukaemia cells for cytarabine-induced cell death by triggering necroptosis.
Chromik J; Safferthal C; Serve H; Fulda S
Cancer Lett; 2014 Mar; 344(1):101-109. PubMed ID: 24184825
[TBL] [Abstract][Full Text] [Related]
4. A Bak-dependent mitochondrial amplification step contributes to Smac mimetic/glucocorticoid-induced necroptosis.
Rohde K; Kleinesudeik L; Roesler S; Löwe O; Heidler J; Schröder K; Wittig I; Dröse S; Fulda S
Cell Death Differ; 2017 Jan; 24(1):83-97. PubMed ID: 27834956
[TBL] [Abstract][Full Text] [Related]
5. Smac mimetics and type II interferon synergistically induce necroptosis in various cancer cell lines.
Cekay MJ; Roesler S; Frank T; Knuth AK; Eckhardt I; Fulda S
Cancer Lett; 2017 Dec; 410():228-237. PubMed ID: 28923396
[TBL] [Abstract][Full Text] [Related]
6. Identification of a novel synergistic induction of cell death by Smac mimetic and HDAC inhibitors in acute myeloid leukemia cells.
Steinwascher S; Nugues AL; Schoeneberger H; Fulda S
Cancer Lett; 2015 Sep; 366(1):32-43. PubMed ID: 26028172
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic targeting of necroptosis by Smac mimetic bypasses apoptosis resistance in acute myeloid leukemia cells.
Safferthal C; Rohde K; Fulda S
Oncogene; 2017 Mar; 36(11):1487-1502. PubMed ID: 27869161
[TBL] [Abstract][Full Text] [Related]
8. Reactive oxygen species regulate Smac mimetic/TNFα-induced necroptotic signaling and cell death.
Schenk B; Fulda S
Oncogene; 2015 Nov; 34(47):5796-806. PubMed ID: 25867066
[TBL] [Abstract][Full Text] [Related]
9. Cotreatment with Smac mimetics and demethylating agents induces both apoptotic and necroptotic cell death pathways in acute lymphoblastic leukemia cells.
Gerges S; Rohde K; Fulda S
Cancer Lett; 2016 May; 375(1):127-132. PubMed ID: 26944210
[TBL] [Abstract][Full Text] [Related]
10. Smac mimetic bypasses apoptosis resistance in FADD- or caspase-8-deficient cells by priming for tumor necrosis factor α-induced necroptosis.
Laukens B; Jennewein C; Schenk B; Vanlangenakker N; Schier A; Cristofanon S; Zobel K; Deshayes K; Vucic D; Jeremias I; Bertrand MJ; Vandenabeele P; Fulda S
Neoplasia; 2011 Oct; 13(10):971-9. PubMed ID: 22028622
[TBL] [Abstract][Full Text] [Related]
11. Smac mimetic and demethylating agents synergistically trigger cell death in acute myeloid leukemia cells and overcome apoptosis resistance by inducing necroptosis.
Steinhart L; Belz K; Fulda S
Cell Death Dis; 2013 Sep; 4(9):e802. PubMed ID: 24030154
[TBL] [Abstract][Full Text] [Related]
12. Loss of FADD and Caspases Affects the Response of T-Cell Leukemia Jurkat Cells to Anti-Cancer Drugs.
Mrkvová Z; Portešová M; Slaninová I
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33800107
[TBL] [Abstract][Full Text] [Related]
13. Novel smac mimetic ASTX660 (Tolinapant) and TNF-α synergistically induce necroptosis in bladder cancer cells in vitro upon apoptosis inhibition.
Wang L; Hu C; Zhao Y; Hu X
Biochem Biophys Res Commun; 2022 Apr; 602():8-14. PubMed ID: 35247703
[TBL] [Abstract][Full Text] [Related]
14. The B-Raf(V600E) inhibitor dabrafenib selectively inhibits RIP3 and alleviates acetaminophen-induced liver injury.
Li JX; Feng JM; Wang Y; Li XH; Chen XX; Su Y; Shen YY; Chen Y; Xiong B; Yang CH; Ding J; Miao ZH
Cell Death Dis; 2014 Jun; 5(6):e1278. PubMed ID: 24901049
[TBL] [Abstract][Full Text] [Related]
15. Identification of a synergistic combination of Smac mimetic and Bortezomib to trigger cell death in B-cell non-Hodgkin lymphoma cells.
Bhatti IA; Abhari BA; Fulda S
Cancer Lett; 2017 Oct; 405():63-72. PubMed ID: 28716527
[TBL] [Abstract][Full Text] [Related]
16. Dichotomy between Receptor-Interacting Protein 1- and Receptor-Interacting Protein 3-Mediated Necroptosis in Experimental Pancreatitis.
Wu J; Mulatibieke T; Ni J; Han X; Li B; Zeng Y; Wan R; Wang X; Hu G
Am J Pathol; 2017 May; 187(5):1035-1048. PubMed ID: 28315674
[TBL] [Abstract][Full Text] [Related]
17. The caspase-8 inhibitor emricasan combines with the SMAC mimetic birinapant to induce necroptosis and treat acute myeloid leukemia.
Brumatti G; Ma C; Lalaoui N; Nguyen NY; Navarro M; Tanzer MC; Richmond J; Ghisi M; Salmon JM; Silke N; Pomilio G; Glaser SP; de Valle E; Gugasyan R; Gurthridge MA; Condon SM; Johnstone RW; Lock R; Salvesen G; Wei A; Vaux DL; Ekert PG; Silke J
Sci Transl Med; 2016 May; 8(339):339ra69. PubMed ID: 27194727
[TBL] [Abstract][Full Text] [Related]
18. Sorafenib tosylate inhibits directly necrosome complex formation and protects in mouse models of inflammation and tissue injury.
Martens S; Jeong M; Tonnus W; Feldmann F; Hofmans S; Goossens V; Takahashi N; Bräsen JH; Lee EW; Van der Veken P; Joossens J; Augustyns K; Fulda S; Linkermann A; Song J; Vandenabeele P
Cell Death Dis; 2017 Jun; 8(6):e2904. PubMed ID: 28661484
[TBL] [Abstract][Full Text] [Related]
19. Necroptosis: Pathway diversity and characteristics.
de Almagro MC; Vucic D
Semin Cell Dev Biol; 2015 Mar; 39():56-62. PubMed ID: 25683283
[TBL] [Abstract][Full Text] [Related]
20. Induction of Necroptosis in Human Breast Cancer Drug-Resistant Cells by SMAC Analog LCL161 After Caspase Inhibition Requires RIP3.
Jin G; Liu Y; Xu P; Jin G
Pharmazie; 2019 Jun; 74(6):363-368. PubMed ID: 31138375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
